Scarica l'app Stockscreener
44.21
13.83%
5.37
Monopar Therapeutics Inc Azioni (MNPR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | 0.0735 |
Operating Expenses
|
0.39%
3.2343
|
3.2218 | 11.07 | 1.5749 | 1.7888 |
| Operating Income/Loss |
0.39%
-3.2343
|
-3.2218 | -11.07 | -1.5749 | -1.7888 |
| Income/Loss From Continuing Operations Before Tax |
6.53%
-2.4535
|
-2.625 | -10.92 | -1.3043 | -1.7153 |
| Income/Loss From Continuing Operations After Tax |
6.53%
-2.4535
|
-2.625 | -10.93 | -1.3043 | -1.7153 |
|
Net Income/Loss
|
6.53%
-2.4535
|
-2.625 | -10.93 | -1.3043 | -1.7153 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.15%
6.9981
|
6.9874 | 0.3709 | 3.5204 | 17.51 |
| Basic Earnings Per Share |
7.89%
-0.35
|
-0.38 | -2.75 | -0.37 | -0.10 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):